The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
The oncogenic transcription factor TAL1/SCL is aberrantly expressed in 60% of cases of human T cell acute lymphoblastic leukemia (T-ALL) and initiates T-ALL in mouse models. By performing global microRNA (miRNA) expression profiling after depletion of TAL1, together with genome-wide analysis of TAL1...
Main Authors: | Mansour, Marc R., Sanda, Takaomi, Lawton, Lee N., Li, Xiaoyu, Kreslavsky, Taras, Novina, Carl D., Brand, Marjorie, Gutierrez, Alejandro, Kelliher, Michelle A., Jamieson, Catriona H. M., von Boehmer, Harald, Young, Richard A., Look, A. Thomas |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Rockefeller University Press
2014
|
Online Access: | http://hdl.handle.net/1721.1/89125 https://orcid.org/0000-0001-8855-8647 |
Similar Items
-
Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
by: Sanda, Takaomi, et al.
Published: (2014) -
TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia
by: Tan, S H, et al.
Published: (2017) -
Recessive lethal amber suppressors in yeast
by: Brandriss, Marjorie Carol.
Published: (2022) -
Functional analysis of cancer-causing FBXW7 mutations
by: Davis, HL
Published: (2012) -
CDC4/FBXW7 and the 'just enough' model of tumourigenesis
by: Davis, H, et al.
Published: (2012)